ojrdrtОнкологический журнал: лучевая диагностика, лучевая терапияJournal of oncology: diagnostic radiology and radiotherapy2587-75932713-167XНЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»10.37174/2587-7593-2025-8-2-96-102ojrdrt-444Research ArticleКОМБИНИРОВАННЫЕ МЕТОДЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯCOMBINED METHODS OF DIAGNOSTICS AND TREATMENTУльтразвуковые гибридные методы визуализации в онкогепатологии.Ultrasound Fusion Imaging In Oncohepatology.https://orcid.org/0000-0002-6171-6796ДанзановаТ. Ю.DanzanovaT. Yu.

115478 Москва, Каширское шоссе, 24

117997, Москва, ул. Островитянова, 1

https://orcid.org/0000-0001-7846-1788ЛепэдатуП. И.LepedatuP. I.

115478 Москва, Каширское шоссе, 24

https://orcid.org/0000-0002-5697-9268СинюковаГ. Т.SinyukovaG. T.

115478 Москва, Каширское шоссе, 24

https://orcid.org/0000-0003-2586-8562БердниковС. Н.BerdnikovS. N.

115478 Москва, Каширское шоссе, 24

https://orcid.org/0000-0002-0193-0563ЗубареваЕ. А.ZubarevaE. A.

117997, Москва, ул. Островитянова, 1

https://orcid.org/0000-0003-4567-9160КовалеваЕ. В.KovalevaE. V.

 Екатерина Вячеславовна Ковалева

143900, Московская обл., Балашиха, ул. Карбышева, 6

Ekaterina V. Kovaleva

6 Karbyshev St., Balashikha, Moscow region,143900

ek.v.kovaleva@gmail.comНациональный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава России; Российский национальный исследовательский медицинский университет имени Н.И. Пирогова Минздрава РоссииРоссияN.N. Blokhin National Medical Research Center of Oncology; Pirogov Russian National Research Medical UniversityRussian FederationНациональный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава РоссииРоссияN.N. Blokhin National Medical Research Center of OncologyRussian FederationРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова Минздрава РоссииРоссияPirogov Russian National Research Medical UniversityRussian FederationOOO «ПЭТ-Технолоджи Балашиха»РоссияLLC “PET- Technology”Russian Federation2025290620258296102Copyright © Данзанова Т.Ю., Лепэдату П.И., Синюкова Г.Т., Бердников С.Н., Зубарева Е.А., Ковалева Е.В., 20252025Данзанова Т.Ю., Лепэдату П.И., Синюкова Г.Т., Бердников С.Н., Зубарева Е.А., Ковалева Е.В.Danzanova T.Y., Lepedatu P.I., Sinyukova G.T., Berdnikov S.N., Zubareva E.A., Kovaleva E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncoradjournal.ru/jour/article/view/444

Представлен обзор литературы по оценке возможностей ультразвуковых гибридных методов визуализации в онкогепатологии. К гибридным, или fusion, технологиям относится совместное применение рентгеновской компьютерной томографии (РКТ) или магнитно-резонансной томографии (МРТ) с серошкальным ультразвуковым исследованием (УЗИ) и УЗИ с контрастным усилением (КУУЗИ). Рассмотрены основные области применения сочетанных лучевых модальностей, таких как первичная дифференциальная диагностика образований печени, навигация для биопсии, а также для проведения термоаблаций. Гибридные технологии диагностики в онкогепатологии повышают совместную чувствительность в выявлении новообразований, позволяют оценить гетерогенность опухоли, определить ее строение и, соответственно, спрогнозировать ответ на лечение.

The article presents a review of the literature concerning the assessment of the possibilities of ultrasound hybrid imaging methods in oncohepathology. Fusion imaging includes the combined use of computed tomography (CT) or magnetic resonance imaging (MRI) with greyscale ultrasound and contrast-enhanced ultrasound (CEUS). The main areas of application of ultrasound fusion imaging, such as differential diagnosis of liver lesions, navigation for biopsy and for thermal ablation. Fusion imaging in oncohepatology increases the sensitivity of the detection of liver lesions, assesses its structure and predicts the response of treatment

гибридное УЗИультразвуковое исследование с контрастным усилениемонкогепатологиябиопсия под контролем УЗИтермоаблация под контролем УЗИhybridultrasonographycontrast-enhanced ultrasoundoncohepatologyUS-guided biopsyUS-guided thermal ablationReferencesSchwarze V, Rübenthaler J, Marschner C, et al. Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRICEUS) in Oncology. Cancers (Basel). 2020;12(10):2821. PMID: 33007933. https://doi.org/10.3390/cancers12102821..Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50. https://doi.org/0.1002/hep.29913.Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50. https://doi.org/0.1002/hep.29913.Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006; 32(9):1369-75. https://doi.org/10.1016/j.ultrasmedbio.2006.05.031.Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006; 32(9):1369-75. https://doi.org/10.1016/j.ultrasmedbio.2006.05.031.Kloth C, Kratzer W, Schmidberger J, et al. Ultrasound 2020 — Diagnostics & Therapy: On the Way to Multimodal Ultrasound: Contrast-Enhanced Ultrasound (CEUS), Microvascular Doppler Techniques, Fusion Imaging, Sonoelastography, Interventional Sonography. Rofo. 2021;193(1):23-32. PMID: 32731265. https://doi.org/10.1055/a-1217-7400.Kloth C, Kratzer W, Schmidberger J, et al. Ultrasound 2020 — Diagnostics & Therapy: On the Way to Multimodal Ultrasound: Contrast-Enhanced Ultrasound (CEUS), Microvascular Doppler Techniques, Fusion Imaging, Sonoelastography, Interventional Sonography. Rofo. 2021;193(1):23-32. PMID: 32731265. https://doi.org/10.1055/a-1217-7400.Huang D, Wen B, Zhang H, et al. Ultrasound fusion imaging for improving diagnostic and therapeutic strategies of focal liver lesions: A preliminary study. J Clin Ultrasound. 2023;51(6):1059-1066. PMID: 37098104. https://doi.org/10.1002/jcu.23467.Huang D, Wen B, Zhang H, et al. Ultrasound fusion imaging for improving diagnostic and therapeutic strategies of focal liver lesions: A preliminary study. J Clin Ultrasound. 2023;51(6):1059-1066. PMID: 37098104. https://doi.org/10.1002/jcu.23467.Barbone GE, Bravin A, Mittone A, et al. High-spatial resolution three-dimensional imaging of human spinal cord and column anatomy with postmortem X-ray phase-contrast micro-CT. Radiology. 2021;298(1):135-46. https://doi.org/10.1148/radiol.2020201622.Barbone GE, Bravin A, Mittone A, et al. High-spatial resolution three-dimensional imaging of human spinal cord and column anatomy with postmortem X-ray phase-contrast micro-CT. Radiology. 2021;298(1):135-46. https://doi.org/10.1148/radiol.2020201622.Sandulescu DL, Dumitrescu D, Rogoveanu I, et al. Hybrid ultrasound imaging techniques (fusion imaging). World J Gastroenterol. 2011;17(1):49-52. PMID: 21218083. https://doi.org/10.3748/wjg.v17.i1.49.Sandulescu DL, Dumitrescu D, Rogoveanu I, et al. Hybrid ultrasound imaging techniques (fusion imaging). World J Gastroenterol. 2011;17(1):49-52. PMID: 21218083. https://doi.org/10.3748/wjg.v17.i1.49.Жуков ОБ, Щеплев ПА. Искусственный интеллект в медицине: от гибридных исследований и клинической валидизации до разработки моделей применения. Андрология и генитальная хирургия. 2019;20(3):14-7. Zhukov О.B., Scheplev P.A. Artificial intelligence in medicine: from hybrid studies and clinical validation to development of application models. Andrology and Genital Surgery. 2019;20(3):14-7. (In Russ.). https://doi.org/10.17650/2070-9781-2019-20-2-00-00.Жуков ОБ, Щеплев ПА. Искусственный интеллект в медицине: от гибридных исследований и клинической валидизации до разработки моделей применения. Андрология и генитальная хирургия. 2019;20(3):14-7. Zhukov О.B., Scheplev P.A. Artificial intelligence in medicine: from hybrid studies and clinical validation to development of application models. Andrology and Genital Surgery. 2019;20(3):14-7. (In Russ.). https://doi.org/10.17650/2070-9781-2019-20-2-00-00.Ewertsen C. Image fusion between ultrasonography and CT, MRI or PET/CT for image guidance and intervention — a the oretical and clinical study. Dan Med Bull. 2010;57(9): B4172. PMID: 20816020.Ewertsen C. Image fusion between ultrasonography and CT, MRI or PET/CT for image guidance and intervention — a the oretical and clinical study. Dan Med Bull. 2010;57(9): B4172. PMID: 20816020.Jung EM, Clevert DA. Contrast-enhanced ultrasound (CEUS) and image fusion for procedures of liver interventions. Radiologe. 2018;58(6):538-44. PMID: 29797043. https://doi.org/10.1007/s00117-018-0411-7.Jung EM, Clevert DA. Contrast-enhanced ultrasound (CEUS) and image fusion for procedures of liver interventions. Radiologe. 2018;58(6):538-44. PMID: 29797043. https://doi.org/10.1007/s00117-018-0411-7.Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227-39. PMID: 25036756. https://doi.org/10.14366/usg.14021.Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227-39. PMID: 25036756. https://doi.org/10.14366/usg.14021.Jung EM, Uller W, Stroszczynski C, et al. Contrast-enhanced sonography. therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma. Radiologe. 2011;51:462-8. PMID: 21557022. https://doi.org/10.1007/s00117-010-2101-y.Jung EM, Uller W, Stroszczynski C, et al. Contrast-enhanced sonography. therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma. Radiologe. 2011;51:462-8. PMID: 21557022. https://doi.org/10.1007/s00117-010-2101-y.Okamoto E, Sato S, Sanchez-Siles AA, et al. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: A prospective pilot study. Am J Roentgenol. 2010;194(5):1272-8. PMID: 20410414. https://doi.org/10.2214/AJR.08.2294.Okamoto E, Sato S, Sanchez-Siles AA, et al. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: A prospective pilot study. Am J Roentgenol. 2010;194(5):1272-8. PMID: 20410414. https://doi.org/10.2214/AJR.08.2294.Bo XW, Xu HX, Wang D, et al. Fusion imaging of contrast enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379. PMID: 27626506. https://doi.org/10.1259/bjr.20160379.Bo XW, Xu HX, Wang D, et al. Fusion imaging of contrast enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379. PMID: 27626506. https://doi.org/10.1259/bjr.20160379.Liu J, Bao D, Xu Z, et al. Clinical value of contrast-enhanced computed tomography (CECT) combined with contrast enhanced ultrasound (CEUS) for characterization and diagnosis of small nodular lesions in liver. Pak J Med Sci. 2021;37(7):1843-8. PMID: 34912405. https://doi.org/10.12669/pjms.37.7.4306.Liu J, Bao D, Xu Z, et al. Clinical value of contrast-enhanced computed tomography (CECT) combined with contrast enhanced ultrasound (CEUS) for characterization and diagnosis of small nodular lesions in liver. Pak J Med Sci. 2021;37(7):1843-8. PMID: 34912405. https://doi.org/10.12669/pjms.37.7.4306.Lee Y, Yoon JH, Han S, et al. Contrast-enhanced ultrasonography–CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome. Cancer Imaging. 2024;24(1):4. PMID: 38172949. https://doi.org/10.1186/s40644-023-00650-y.Lee Y, Yoon JH, Han S, et al. Contrast-enhanced ultrasonography–CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome. Cancer Imaging. 2024;24(1):4. PMID: 38172949. https://doi.org/10.1186/s40644-023-00650-y.Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136-43. PMID: 23993075. https://doi.org/10.1053/j.tvir.2013.02.008.Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136-43. PMID: 23993075. https://doi.org/10.1053/j.tvir.2013.02.008.Lee MW, Lim HK, Kim YJ, et al. Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session. J Ultrasound Med. 2011;30(5):607-615. PMID: 21527608. https://doi.org/10.7863/jum.2011.30.5.607.Lee MW, Lim HK, Kim YJ, et al. Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session. J Ultrasound Med. 2011;30(5):607-615. PMID: 21527608. https://doi.org/10.7863/jum.2011.30.5.607.Данзанова ТЮ, Синюкова ГТ, Гудилина ЕА и др. Значение ультразвуковой диагностики метастатического поражения печени в определении тактики хирургического лечения. Российский онкологический журнал. 2015;2(3):23-27. Danzanova TYu, Sinyukova GT, Gudilina EA, et al. The role of ultrasonic diagnostics of liver metastates in designing surgical treatment strategy. Russian Onkology Journal. 2015;20(3):23-27. (In Russ.).Данзанова ТЮ, Синюкова ГТ, Гудилина ЕА и др. Значение ультразвуковой диагностики метастатического поражения печени в определении тактики хирургического лечения. Российский онкологический журнал. 2015;2(3):23-27. Danzanova TYu, Sinyukova GT, Gudilina EA, et al. The role of ultrasonic diagnostics of liver metastates in designing surgical treatment strategy. Russian Onkology Journal. 2015;20(3):23-27. (In Russ.).Ковалева ЕВ, Синюкова ГТ, Данзанова ТЮ и др. Возможности УЗИ с применением контрастного усиления в диагностике метастазов в печени у больных колоректальным раком. Колопроктология. 2018;1(63):36-41. Kovaleva EV, Sinyukova GT, Danzanova TYU, et al. The possibilities of contrast enhaced ultrasound (CEUS) in the diagnosis of colorectal liver metastases (CRLM). Coloproctology. 2018;1(63):36-41. (In Russ.).Ковалева ЕВ, Синюкова ГТ, Данзанова ТЮ и др. Возможности УЗИ с применением контрастного усиления в диагностике метастазов в печени у больных колоректальным раком. Колопроктология. 2018;1(63):36-41. Kovaleva EV, Sinyukova GT, Danzanova TYU, et al. The possibilities of contrast enhaced ultrasound (CEUS) in the diagnosis of colorectal liver metastases (CRLM). Coloproctology. 2018;1(63):36-41. (In Russ.).Park HS, Young JK, Mi HY, et al. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging. J Ultrasound Med. 2015;34(3):411-21. PMID: 25715362. https://doi.org/10.7863/ultra.34.3.411.Park HS, Young JK, Mi HY, et al. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging. J Ultrasound Med. 2015;34(3):411-21. PMID: 25715362. https://doi.org/10.7863/ultra.34.3.411.Kang TW, Min WL, Kyoung DS, et al. Added value of contrast enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance. Korean J Radiol. 2017;18(1):152-61. PMID: 28096725. https://doi.org/10.3348/kjr.2017.18.1.152.Kang TW, Min WL, Kyoung DS, et al. Added value of contrast enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance. Korean J Radiol. 2017;18(1):152-61. PMID: 28096725. https://doi.org/10.3348/kjr.2017.18.1.152.Lee DH, Lee J. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, real-time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19(4):545-59. PMID: 29962861. https://doi.org/10.3348/kjr.2018.19.4.545.Lee DH, Lee J. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, real-time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19(4):545-59. PMID: 29962861. https://doi.org/10.3348/kjr.2018.19.4.545.Москвичева ЛИ, Сидоров ДВ, Ложкин МВ и др. Современные методы аблации злокачественных новообразований печени. Исследования и практика в медицине. 2018;5(4): 58‑71. Moskvicheva LI, Sidorov DV, Lozhkin MV, et al. Modern methods of ablation of malignant tumors of the liver. Research’n Practical Medicine Journal. 2018;5(4):58-71. (In Russ.). https://doi.org/10.17709/2409-2231-2018-5-4-6.Москвичева ЛИ, Сидоров ДВ, Ложкин МВ и др. Современные методы аблации злокачественных новообразований печени. Исследования и практика в медицине. 2018;5(4): 58‑71. Moskvicheva LI, Sidorov DV, Lozhkin MV, et al. Modern methods of ablation of malignant tumors of the liver. Research’n Practical Medicine Journal. 2018;5(4):58-71. (In Russ.). https://doi.org/10.17709/2409-2231-2018-5-4-6.Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017;90(1078):20170063. PMID: 28749166. https://doi.org/10.1259/bjr.20170063.Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017;90(1078):20170063. PMID: 28749166. https://doi.org/10.1259/bjr.20170063.Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology. 2000;217:558-63. PMID: 11058660. https://doi.org/10.1148/radiology.217.2.r00oc07558.Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology. 2000;217:558-63. PMID: 11058660. https://doi.org/10.1148/radiology.217.2.r00oc07558.Salvaggio G, Campisi A, Lo Greco V, et al. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging. 2010;35(4):447-53. PMID: 19562414. https://doi.org/10.1007/s00261-009-9551-6.Salvaggio G, Campisi A, Lo Greco V, et al. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging. 2010;35(4):447-53. PMID: 19562414. https://doi.org/10.1007/s00261-009-9551-6.Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol. 2012;81(8):e897-902. PMID: 22658846. https://doi.org/10.1016/j.ejrad.2012.05.002.Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol. 2012;81(8):e897-902. PMID: 22658846. https://doi.org/10.1016/j.ejrad.2012.05.002.Sparchez Z, Radu P, Anton O, et al. Contrast enhanced ultrasound in assessing therapeutic response in ablative treatments of hepatocellular carcinoma. J Gastrointestin Liver Dis. 2009;18(2):243-8. PMID: 19565061.Sparchez Z, Radu P, Anton O, et al. Contrast enhanced ultrasound in assessing therapeutic response in ablative treatments of hepatocellular carcinoma. J Gastrointestin Liver Dis. 2009;18(2):243-8. PMID: 19565061.Minami Y, Kudo M. Image guidance in ablation for hepatocellular carcinoma: contrast-enhanced ultrasound and fusion imaging. Front. Oncol. 2021;11:593636. PMID: 33747913. https://doi.org/10.3389/fonc.2021.593636.Minami Y, Kudo M. Image guidance in ablation for hepatocellular carcinoma: contrast-enhanced ultrasound and fusion imaging. Front. Oncol. 2021;11:593636. PMID: 33747913. https://doi.org/10.3389/fonc.2021.593636.Huang Q, Zeng Q, Long Y, et al. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma — A prospective randomized controlled trial. Int J Hyperthermia. 2019;36(1):1207-15. PMID: 31813295. https://doi.org/10.1080/02656736.2019.1687945.Huang Q, Zeng Q, Long Y, et al. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma — A prospective randomized controlled trial. Int J Hyperthermia. 2019;36(1):1207-15. PMID: 31813295. https://doi.org/10.1080/02656736.2019.1687945.Singh BS, Cazacu IM, Deza CA, et al. Image fusion involving real-time transabdominal or endoscopic ultrasound for gastrointestinal malignancies: review of current and future applications. Diagnostics (Basel). 2022;12(12):3218. PMID: 36553225. https://doi.org/10.3390/diagnostics12123218.Singh BS, Cazacu IM, Deza CA, et al. Image fusion involving real-time transabdominal or endoscopic ultrasound for gastrointestinal malignancies: review of current and future applications. Diagnostics (Basel). 2022;12(12):3218. PMID: 36553225. https://doi.org/10.3390/diagnostics12123218.Манукян МШ, Базин ИС, Трякин АА. Особенности мутаций в гене KRAS в реальной клинической практике при раке поджелудочной железы. Хирургия и онкология. 2025;15(1):28-35. Manukyan MSh, Bazin IS, Tryakin AA. Characteristics of KRAS gene mutations in real clinical practice for pancreatic cancer. Surgery and Oncology. 2025;15(1):28-35. (In Russ.). https://doi.org/10.17650/2949-5857-2025-15-1-28-35Манукян МШ, Базин ИС, Трякин АА. Особенности мутаций в гене KRAS в реальной клинической практике при раке поджелудочной железы. Хирургия и онкология. 2025;15(1):28-35. Manukyan MSh, Bazin IS, Tryakin AA. Characteristics of KRAS gene mutations in real clinical practice for pancreatic cancer. Surgery and Oncology. 2025;15(1):28-35. (In Russ.). https://doi.org/10.17650/2949-5857-2025-15-1-28-35Фисенко ЕП, Аллахвердиева ГФ, Данзанова ТЮ и др. Обоснование создания новой классификации оценки поверхностных лимфатических узлов US NODE-RADS (российская версия) по данным ультразвукового исследования: согласованное мнение экспертов Российской ассоциации специалистов ультразвуковой диагностики в медицине. Хирургия и онкология. 2024;14(3):11-7. https://doi.org/10.17650/2949-5857-2024-14-3-11-17Фисенко ЕП, Аллахвердиева ГФ, Данзанова ТЮ и др. Обоснование создания новой классификации оценки поверхностных лимфатических узлов US NODE-RADS (российская версия) по данным ультразвукового исследования: согласованное мнение экспертов Российской ассоциации специалистов ультразвуковой диагностики в медицине. Хирургия и онкология. 2024;14(3):11-7. https://doi.org/10.17650/2949-5857-2024-14-3-11-17Bansal S, Gui J, Merrill C, et al. Contrast-enhanced US in local ablative therapy and secondary surveillance for hepatocellular carcinoma. Radiographics. 2019;39(5):1302-22. PMID: 31348734. https://doi.org/10.1148/rg.2019180205.Bansal S, Gui J, Merrill C, et al. Contrast-enhanced US in local ablative therapy and secondary surveillance for hepatocellular carcinoma. Radiographics. 2019;39(5):1302-22. PMID: 31348734. https://doi.org/10.1148/rg.2019180205.Numata K, Fukuda H, Nihonmatsu H, et al. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic Liver Disease. Abdom Imaging. 2015;40(7):2372-83. PMID: 26099473. https://doi.org/10.1007/s00261-015-0489-6.Numata K, Fukuda H, Nihonmatsu H, et al. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic Liver Disease. Abdom Imaging. 2015;40(7):2372-83. PMID: 26099473. https://doi.org/10.1007/s00261-015-0489-6.

The authors declare that there are no conflicts of interest present.